1. GPCR/G Protein Neuronal Signaling PROTAC
  2. Dopamine Receptor mAChR Adrenergic Receptor 5-HT Receptor Ligands for E3 Ligase
  3. Clozapine

Clozapine  (Synonyms: HF 1854; ZINC000019796155)

Cat. No.: HY-14539 Purity: 99.84%
Handling Instructions Technical Support

Clozapine (HF 1854) is an antipsychotic used for the research of schizophrenia. Clozapine has high affinity for a number of neuroreceptors. Clozapine is a potent antagonist of dopamine D2 with a Ki of 75 nM. Clozapine inhibits the muscarinic M1 receptor and serotonin 5HT2A receptor with Kis of 9.5 nM and 4 nM, respectively. Clozapine is also a potent and selective agonist at the muscarinic M4 receptor (EC50=11 nM).

For research use only. We do not sell to patients.

CAS No. : 5786-21-0

Size Price Stock Quantity
Solid + Solvent (Highly Recommended)
10 mM * 1 mL in DMSO
ready for reconstitution
In-stock
Solution
10 mM * 1 mL in DMSO In-stock
Solid
50 mg In-stock
100 mg In-stock
250 mg In-stock
500 mg In-stock
1 g In-stock
5 g   Get quote  
10 g   Get quote  

* Please select Quantity before adding items.

This product is a controlled substance and not for sale in your territory.

Customer Review

Based on 11 publication(s) in Google Scholar

Other Forms of Clozapine:

Top Publications Citing Use of Products

    Clozapine purchased from MedChemExpress. Usage Cited in: Nat Commun. 2025 Dec 13;16(1):11318.  [Abstract]

    In isoflurane anesthetized mice, the injection of Clozapine (0.03 mg/kg; i.p.) significantly increased EEG-based arousal index, but from a low to middle arousal level.

    Clozapine purchased from MedChemExpress. Usage Cited in: Nat Commun. 2024 Sep 1;15(1):7603.  [Abstract]

    Representative current clamp recording of a NPYDRN/vlPAG-hM4Di neuron with the bath of Clozapine (5 μM). Average membrane potential and firing frequency before and after Clozapine application to inhibit NPY DRN/vlPAGneurons were also recorded. Clozapine effectively inhibited hM4Di+ NPYDRN/vlPAG neurons with decreased neuronal membrane potential and firing frequency.

    Clozapine purchased from MedChemExpress. Usage Cited in: Nat Commun. 2024 Sep 1;15(1):7603.  [Abstract]

    Percentage of body weight changes, daily food intake and its area under curve (AUC) of mCherry-restraint and hM4Di-restraint mice. Clozapine (i.p.; 0.2mg/kg; 30 min before restraint for 14 d) caused NPYhM4Di mice to consume less food and lost more body weight than NPYmCherry mice during chronic restraint stress.

    Clozapine purchased from MedChemExpress. Usage Cited in: FEBS J. 2024 Nov;291(21):4680-4695.  [Abstract]

    HaCaT cells were transfected with siNC or siRNA against TRPM7 and then treated with Clozapine (Clo) (10 μM; 6 d) the next day. Clozapine (Clo) promoted activation of TRPM7 and increased SA-b-Gal activity.

    Clozapine purchased from MedChemExpress. Usage Cited in: Mol Psychiatry. 2021 Jun;26(6):2514-2532.  [Abstract]

    The administration of Clozapine (i.p.; 2 d) restored impaired PPI in female ZFP804A mutant mice.
    • Biological Activity

    • Purity & Documentation

    • References

    • Customer Review

    Description

    Clozapine (HF 1854) is an antipsychotic used for the research of schizophrenia. Clozapine has high affinity for a number of neuroreceptors. Clozapine is a potent antagonist of dopamine D2 with a Ki of 75 nM. Clozapine inhibits the muscarinic M1 receptor and serotonin 5HT2A receptor with Kis of 9.5 nM and 4 nM, respectively[1][2][3]. Clozapine is also a potent and selective agonist at the muscarinic M4 receptor (EC50=11 nM)[4].

    IC50 & Target[1][4]

    5-HT2A Receptor

    4 nM (Ki, Inhibitor)

    5-HT2A Receptor

     

    5-HT6 Receptor

     

    5-HT7 Receptor

     

    mAChR1

    9.5 nM (Ki, Antagonist)

    mAChR4

    11 nM (EC50, Agonist)

    α2-adrenergic receptor

    51 nM (Ki, Inhibitor)

    D2 Receptor

    75 nM (Ki, Antagonist)

    Cellular Effect
    Cell Line Type Value Description References
    CHO EC50
    56 μM
    Compound: clozapine
    Cytotoxicity against CHO cells by MTT assay
    Cytotoxicity against CHO cells by MTT assay
    [PMID: 17870534]
    CHO IC50
    0.058 μM
    Compound: clozapine
    Inhibitory concentration against human Dopamine receptor D4.2 in CHO cells
    Inhibitory concentration against human Dopamine receptor D4.2 in CHO cells
    [PMID: 8831770]
    CHO IC50
    206 nM
    Compound: 1
    Inhibition of human dopamine D2L receptor expressed in intact CHO FlpIn cells assessed as inhibition of receptor-mediated mediated ERK1/2 phosphorylation by Alpha-Screen plate-based assay
    Inhibition of human dopamine D2L receptor expressed in intact CHO FlpIn cells assessed as inhibition of receptor-mediated mediated ERK1/2 phosphorylation by Alpha-Screen plate-based assay
    [PMID: 22243698]
    CHO IC50
    3.6 μM
    Compound: clozapine
    Inhibition of Cav1.2 current measured using QPatch automatic path clamp system in CHO cells expressing Cav1.2, beta-2 and alpha-2/delta-1 subunits
    Inhibition of Cav1.2 current measured using QPatch automatic path clamp system in CHO cells expressing Cav1.2, beta-2 and alpha-2/delta-1 subunits
    [PMID: 23812503]
    CHO IC50
    4.1 x 10-8 M
    Compound: Clozapine
    Displacement of [3H]methylspiperone from human recombinant Dopamine D4.4 receptor expressed in CHO cells
    Displacement of [3H]methylspiperone from human recombinant Dopamine D4.4 receptor expressed in CHO cells
    [PMID: 26988801]
    CHO IC50
    4.1 x 10-8 M
    Compound: Clozapine
    Displacement of [3H]methyl-spiperone from human recombinant dopamine D4.4 receptor expressed in CHO cells measured after 60 mins by scintillation counting method
    Displacement of [3H]methyl-spiperone from human recombinant dopamine D4.4 receptor expressed in CHO cells measured after 60 mins by scintillation counting method
    [PMID: 27876250]
    CHO-K1 IC50
    9.4 nM
    Compound: 1
    Inhibitory binding of [3H]pirenzepine to human Muscarinic acetylcholine receptor M1 in membranes from CHO-K1 cells
    Inhibitory binding of [3H]pirenzepine to human Muscarinic acetylcholine receptor M1 in membranes from CHO-K1 cells
    [PMID: 9406603]
    CHO-K1 IC50
    9.4 nM
    Compound: 4
    Inhibition of binding of 1.0 nM [3H]pirenzepine to cloned human Muscarinic acetylcholine receptor M1 expressed in membranes from CHO-K1 cells
    Inhibition of binding of 1.0 nM [3H]pirenzepine to cloned human Muscarinic acetylcholine receptor M1 expressed in membranes from CHO-K1 cells
    [PMID: 10377229]
    HEK293 IC50
    650 nM
    Compound: Clozapine
    Inhibition of human ERG expressed in HEK293 cells by electrophysiology assay
    Inhibition of human ERG expressed in HEK293 cells by electrophysiology assay
    [PMID: 23675993]
    HeLa IC50
    17 nM
    Compound: Clozapine
    Displacement of [3H]LSD from human cloned 5-HT6 receptor expressed in HeLa cells
    Displacement of [3H]LSD from human cloned 5-HT6 receptor expressed in HeLa cells
    [PMID: 24495863]
    Sf21 IC50
    126.1 μM
    Compound: Clozapine
    Inhibition of human BSEP expressed in plasma membrane vesicles of Sf21 cells assessed as inhibition of ATP-dependent [3H]taurocholate uptake
    Inhibition of human BSEP expressed in plasma membrane vesicles of Sf21 cells assessed as inhibition of ATP-dependent [3H]taurocholate uptake
    [PMID: 21965623]
    Sf21 IC50
    196.5 μM
    Compound: Clozapine
    Inhibition of Sprague-Dawley rat Bsep expressed in plasma membrane vesicles of Sf21 cells assessed as inhibition of ATP-dependent [3H]taurocholate uptake
    Inhibition of Sprague-Dawley rat Bsep expressed in plasma membrane vesicles of Sf21 cells assessed as inhibition of ATP-dependent [3H]taurocholate uptake
    [PMID: 21965623]
    WI-38 CC50
    40 μM
    Compound: Clozapine
    Cytotoxicity against human WI38 cells assessed as reduction in cellular DNA level preincubated for 2 hrs before viral infection measured after 7 days by real time PCR assay
    Cytotoxicity against human WI38 cells assessed as reduction in cellular DNA level preincubated for 2 hrs before viral infection measured after 7 days by real time PCR assay
    [PMID: 17893158]
    WI-38 EC50
    23.26 μM
    Compound: Clozapine
    Antiviral activity against BKV Gardner ATCC VR837 infected in human WI38 cells assessed as reduction in viral DNA level preincubated for 2 hrs before viral infection measured after 7 days by real time PCR assay
    Antiviral activity against BKV Gardner ATCC VR837 infected in human WI38 cells assessed as reduction in viral DNA level preincubated for 2 hrs before viral infection measured after 7 days by real time PCR assay
    [PMID: 17893158]
    In Vitro

    Clozapine (HF 1854) is a D2 receptor antagonist with a Ki of 75 nM, blocks the serotonin 5HT2A receptor with a Ki of 4 nM, inhibits the muscarinic M1 receptor with a Ki of 9.5 nM, blocks α2-adrenoceptor with a Ki value of 51 nM[1].
    Clozapine (0-1 μM; 24 h) downregulates 5-HT6 and upregulates 5-HT7 receptors in HeLa cells[2].
    Clozapine is a full agonist at the muscarinic M4 receptor (EC50=11 nM) expressed in CHO cells[4].

    MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.

    In Vivo

    Clozapine (HF 1854) (25 mg/kg/day; i.p.; 21 days) shows antipsychotic effects in lysergic acid diethylamide-induced psychosis mouse model[3].

    MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.

    Animal Model: Male 129 S6/Sv mice, lysergic acid diethylamide (LSD)-induced psychosis model[3]
    Dosage: 25 mg/kg/day
    Administration: Intraperitoneal injection, 21 days
    Result: Decreased head-twitch response, reduced 5-HT2A mRNA, rescued induction of c-fos, but not egr-1 and egr-2.
    Molecular Weight

    326.83

    Formula

    C18H19ClN4

    CAS No.
    Appearance

    Solid

    Color

    Light yellow to yellow

    SMILES

    CN1CCN(CC1)C2=NC3=CC(Cl)=CC=C3NC4=CC=CC=C42

    Shipping

    Room temperature in continental US; may vary elsewhere.

    Storage
    Powder -20°C 3 years
    4°C 2 years
    In solvent -80°C 1 year
    -20°C 6 months
    Solvent & Solubility
    In Vitro: 

    DMSO : 50 mg/mL (152.98 mM; Need ultrasonic; Hygroscopic DMSO has a significant impact on the solubility of product, please use newly opened DMSO)

    Preparing
    Stock Solutions
    Concentration Solvent Mass 1 mg 5 mg 10 mg
    1 mM 3.0597 mL 15.2985 mL 30.5969 mL
    5 mM 0.6119 mL 3.0597 mL 6.1194 mL
    View the Complete Stock Solution Preparation Table

    * Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
    Storage method and period of stock solution: -80°C, 1 year; -20°C, 6 months. When stored at -80°C, please use it within 1 year. When stored at -20°C, please use it within 6 months.

    • Molarity Calculator

    • Dilution Calculator

    Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

    Mass
    =
    Concentration
    ×
    Volume
    ×
    Molecular Weight *

    Concentration (start) × Volume (start) = Concentration (final) × Volume (final)

    This equation is commonly abbreviated as: C1V1 = C2V2

    Concentration (start)

    C1

    ×
    Volume (start)

    V1

    =
    Concentration (final)

    C2

    ×
    Volume (final)

    V2

    In Vivo:

    Select the appropriate dissolution method based on your experimental animal and administration route.

    For the following dissolution methods, please ensure to first prepare a clear stock solution using an In Vitro approach and then sequentially add co-solvents:
    To ensure reliable experimental results, the clarified stock solution can be appropriately stored based on storage conditions. As for the working solution for in vivo experiments, it is recommended to prepare freshly and use it on the same day.
    The percentages shown for the solvents indicate their volumetric ratio in the final prepared solution. If precipitation or phase separation occurs during preparation, heat and/or sonication can be used to aid dissolution.

    • Protocol 1

      Add each solvent one by one:  10% DMSO    40% PEG300    5% Tween-80    45% Saline

      Solubility: ≥ 2.5 mg/mL (7.65 mM); Clear solution

      This protocol yields a clear solution of ≥ 2.5 mg/mL (saturation unknown).

      Taking 1 mL working solution as an example, add 100 μL DMSO stock solution (25.0 mg/mL) to 400 μL PEG300, and mix evenly; then add 50 μL Tween-80 and mix evenly; then add 450 μL Saline to adjust the volume to 1 mL.

      Preparation of Saline: Dissolve 0.9 g sodium chloride in ddH₂O and dilute to 100 mL to obtain a clear Saline solution.
    • Protocol 2

      Add each solvent one by one:  10% DMSO    90% (20% SBE-β-CD in Saline)

      Solubility: ≥ 2.5 mg/mL (7.65 mM); Clear solution

      This protocol yields a clear solution of ≥ 2.5 mg/mL (saturation unknown).

      Taking 1 mL working solution as an example, add 100 μL DMSO stock solution (25.0 mg/mL) to 900 μL 20% SBE-β-CD in Saline, and mix evenly.

      Preparation of 20% SBE-β-CD in Saline (4°C, storage for one week): 2 g SBE-β-CD powder is dissolved in 10 mL Saline, completely dissolve until clear.
    In Vivo Dissolution Calculator
    Please enter the basic information of animal experiments:

    Dosage

    mg/kg

    Animal weight
    (per animal)

    g

    Dosing volume
    (per animal)

    μL

    Number of animals

    Recommended: Prepare an additional quantity of animals to account for potential losses during experiments.
    Please enter your animal formula composition:
    %
    DMSO +
    +
    %
    Tween-80 +
    %
    Saline
    Recommended: Keep the proportion of DMSO in working solution below 2% if your animal is weak.
    The co-solvents required include: DMSO, . All of co-solvents are available by MedChemExpress (MCE). , Tween 80. All of co-solvents are available by MedChemExpress (MCE).
    Calculation results:
    Working solution concentration: mg/mL
    Method for preparing stock solution: mg drug dissolved in μL  DMSO (Stock solution concentration: mg/mL).
    The concentration of the stock solution you require exceeds the measured solubility. The following solution is for reference only. If necessary, please contact MedChemExpress (MCE).
    Method for preparing in vivo working solution for animal experiments: Take μL DMSO stock solution, add μL . μL , mix evenly, next add μL Tween 80, mix evenly, then add μL Saline.
     If the continuous dosing period exceeds half a month, please choose this protocol carefully.
    Please ensure that the stock solution in the first step is dissolved to a clear state, and add co-solvents in sequence. You can use ultrasonic heating (ultrasonic cleaner, recommended frequency 20-40 kHz), vortexing, etc. to assist dissolution.
    Purity & Documentation
    References

    Complete Stock Solution Preparation Table

    * Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
    Storage method and period of stock solution: -80°C, 1 year; -20°C, 6 months. When stored at -80°C, please use it within 1 year. When stored at -20°C, please use it within 6 months.

    Optional Solvent Concentration Solvent Mass 1 mg 5 mg 10 mg 25 mg
    DMSO 1 mM 3.0597 mL 15.2985 mL 30.5969 mL 76.4924 mL
    5 mM 0.6119 mL 3.0597 mL 6.1194 mL 15.2985 mL
    10 mM 0.3060 mL 1.5298 mL 3.0597 mL 7.6492 mL
    15 mM 0.2040 mL 1.0199 mL 2.0398 mL 5.0995 mL
    20 mM 0.1530 mL 0.7649 mL 1.5298 mL 3.8246 mL
    25 mM 0.1224 mL 0.6119 mL 1.2239 mL 3.0597 mL
    30 mM 0.1020 mL 0.5099 mL 1.0199 mL 2.5497 mL
    40 mM 0.0765 mL 0.3825 mL 0.7649 mL 1.9123 mL
    50 mM 0.0612 mL 0.3060 mL 0.6119 mL 1.5298 mL
    60 mM 0.0510 mL 0.2550 mL 0.5099 mL 1.2749 mL
    80 mM 0.0382 mL 0.1912 mL 0.3825 mL 0.9562 mL
    100 mM 0.0306 mL 0.1530 mL 0.3060 mL 0.7649 mL
    • No file chosen (Maximum size is: 1024 Kb)
    • If you have published this work, please enter the PubMed ID.
    • Your name will appear on the site.
    Help & FAQs
    • Do most proteins show cross-species activity?

      Species cross-reactivity must be investigated individually for each product. Many human cytokines will produce a nice response in mouse cell lines, and many mouse proteins will show activity on human cells. Other proteins may have a lower specific activity when used in the opposite species.

    Your Recently Viewed Products:

    Inquiry Online

    Your information is safe with us. * Required Fields.

    Product Name

     

    Requested Quantity *

    Applicant Name *

     

    Salutation

    Email Address *

     

    Phone Number *

    Department

     

    Organization Name *

    City

    State

    Country or Region *

         

    Remarks

    Bulk Inquiry

    Inquiry Information

    Product Name:
    Clozapine
    Cat. No.:
    HY-14539
    Quantity:
    MCE Japan Authorized Agent: